BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 18391177)

  • 1. Physiology of the prion protein.
    Linden R; Martins VR; Prado MA; Cammarota M; Izquierdo I; Brentani RR
    Physiol Rev; 2008 Apr; 88(2):673-728. PubMed ID: 18391177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.
    Nicolas O; Gavín R; del Río JA
    Brain Res Rev; 2009 Oct; 61(2):170-84. PubMed ID: 19523487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein induced signaling cascades in monocytes.
    Krebs B; Dorner-Ciossek C; Schmalzbauer R; Vassallo N; Herms J; Kretzschmar HA
    Biochem Biophys Res Commun; 2006 Feb; 340(1):13-22. PubMed ID: 16343423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular prion protein signaling in serotonergic neuronal cells.
    Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
    Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on the serotoninergic system in sub-acute transmissible spongiform encephalopathies: current data, hypotheses, suggestions for experimentation.
    Ledoux JM
    Med Hypotheses; 2005; 64(5):910-8. PubMed ID: 15780484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological role of the cellular prion protein.
    Zomosa-Signoret V; Arnaud JD; Fontes P; Alvarez-Martinez MT; Liautard JP
    Vet Res; 2008; 39(4):9. PubMed ID: 18073096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.
    Heiseke A; Schöbel S; Lichtenthaler SF; Vorberg I; Groschup MH; Kretzschmar H; Schätzl HM; Nunziante M
    Traffic; 2008 Jul; 9(7):1116-29. PubMed ID: 18419754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transmissible spongiform encephalopathies.
    Lasmézas CI
    Rev Sci Tech; 2003 Apr; 22(1):23-36. PubMed ID: 12793772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of the immunological system in the pathogenesis of transmissible spongiform encephalopathies].
    Brun A; Castilla J; Parra B; Rodríguez F; Torres JM
    Rev Neurol; 2003 Oct 1-15; 37(7):648-53. PubMed ID: 14582023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated silver, barium and strontium in antlers, vegetation and soils sourced from CWD cluster areas: do Ag/Ba/Sr piezoelectric crystals represent the transmissible pathogenic agent in TSEs?
    Purdey M
    Med Hypotheses; 2004; 63(2):211-25. PubMed ID: 15236778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis.
    Aguzzi A
    J Neurochem; 2006 Jun; 97(6):1726-39. PubMed ID: 16805779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains.
    Ersdal C; Goodsir CM; Simmons MM; McGovern G; Jeffrey M
    Neuropathol Appl Neurobiol; 2009 Jun; 35(3):259-71. PubMed ID: 19473293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion diseases and the immune system.
    Aucouturier P; Carp RI; Carnaud C; Wisniewski T
    Clin Immunol; 2000 Aug; 96(2):79-85. PubMed ID: 10900153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic approaches targeting the prion receptor LRP/LR.
    Zuber C; Ludewigs H; Weiss S
    Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions: protein aggregation and infectious diseases.
    Aguzzi A; Calella AM
    Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intriguing nucleic-acid-binding features of mammalian prion protein.
    Silva JL; Lima LM; Foguel D; Cordeiro Y
    Trends Biochem Sci; 2008 Mar; 33(3):132-40. PubMed ID: 18243708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
    Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
    J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
    Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.